Home/Filings/4/0001179110-22-003076
4//SEC Filing

Gosebruch Henry O 4

Accession 0001179110-22-003076

CIK 0001551152other

Filed

May 17, 8:00 PM ET

Accepted

May 18, 5:12 PM ET

Size

10.0 KB

Accession

0001179110-22-003076

Insider Transaction Report

Form 4
Period: 2022-05-16
Gosebruch Henry O
Chief Strategy Officer
Transactions
  • Exercise/Conversion

    Common Stock, $0.01 par value

    2022-05-16$54.86/sh+83,960$4,606,046100,583 total
  • Sale

    Common Stock, $0.01 par value

    2022-05-16$155.00/sh83,960$13,013,80016,623 total
  • Exercise/Conversion

    Option (Right to Buy)

    2022-05-16$54.86/sh83,960$4,606,0460 total
    Exercise: $54.86From: 2017-02-18Exp: 2026-02-17Common Stock (83,960 underlying)
Holdings
  • Common Stock, $0.01 par value

    (indirect: By Trust)
    78,500
  • Common Stock, $0.01 par value

    (indirect: By Trust)
    3,457
Footnotes (3)
  • [F1]The reporting person is trustee of a trust established for the benefit of his children. The reporting person disclaims beneficial ownership of all securities held by the trust.
  • [F2]Balance in AbbVie Savings program as of January 31, 2022.
  • [F3]Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Issuer

AbbVie Inc.

CIK 0001551152

Entity typeother

Related Parties

1
  • filerCIK 0001659625

Filing Metadata

Form type
4
Filed
May 17, 8:00 PM ET
Accepted
May 18, 5:12 PM ET
Size
10.0 KB